Volume : 10, Issue : 03, March – 2023
Title:
10.FORMULATION AND CHARACTERIZATION OF ANTI- HYPERTENSIVE DRUG NANO PARTICLE
Authors :
A Vineeth kumar, P. Neeraja
Abstract :
Nanoparticles are defined as particulate dispersions or solid particles with a size in the range of 10-1000nm. The main use of the polymeric nanoparticles was to deliver the drug to the appropriate site and also to achieve the effective, controlled, protective drug delivery without any toxic side effects. By using this fenugreek seed polymer Diltiazem HCl which has short half-life was successfully incorporated to retard the drug release and prevent the drug degradation. The present research work revealed the use of fenugreek seed polymer as an effective rate controlling polymer in preparation of polymeric nanoparticles by desolvation method. From this study we concluded that the use of natural polymers for the preparation of nanoparticles is beneficial than toxic synthetic polymers.
Keywords: Formulation, Characterization, Anti-Hypertensive Drug, Nano Particle.
Cite This Article:
Please cite this article in press A Vineeth kumar et al, Formulation And Characterization Of Anti-Hypertensive Drug Nano Particle., Indo Am. J. P. Sci, 2023; 10 (03).
Number of Downloads : 10
References:
1. Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory’s experience. Acc Chem Res 2000; 33: 94-101.
2. Bhadra D, Bhadra S, Jain P, Jain NK. Pegnology: a review of PEG-ylated systems. Pharmazie 2002; 57: 5-29.
3. Kommareddy S, Tiwari SB, Amiji MM. Long-circulating polymeric nanovectors for tumor-selective gene delivery. Technol Cancer Res Treat 2005;
4. 615- 25. 4. Lee M, Kim SW. Polyethylene glycol-conjugated copolymers for plasmid DNA delivery. Pharm Res 2005; 22: 1-10.
5. Vila A, Sanchez A, Tobio M, Calvo P, Alonso MJ. Design of biodegradable particles for protein delivery. J Control Release 2002; 78: 15-24.
6. Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol(R)): PLGA nanoparticles containing vitamin E TPGS. J Control Release 2003; 86: 33-48.
7. Kreuter J. Nanoparticles. In Colloidal drug delivery systems, J, K., Ed. Marcel Dekker: New York, 1994; pp 219-342.
8. Reverchon E, Adami R. Nanomaterials and supercritical fluids. The Journal of Supercritical Fluids 2006; 37: 1-22.
9. Rolland JP, Maynor BW, Euliss LE, Exner AE, Denison GM, DeSimone JM. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. J. Am. Chem. Soc. 2005; 127: 10096-10100
10. Kompella UB, Bandi N, Ayalasomayajula SP. Poly (lactic acid) nanoparticles for sustained release of budesonide. Drug Deliv. Technol. 2001; 1: 1-7.
11. Ravi MN, Bakowsky U, Lehr CM. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 2004; 25: 1771-1777.
12. Li YP, Pei YY, Zhou ZH, Zhang XY, Gu ZH, Ding J, Zhou JJ, Gao, XJ, PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-[alpha] carriers. J Control Release 2001; 71: 287-296.